Clinical Trial Update: How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing gradual dose escalation of Avonex versus starting at full dose to influence side effects in relapsing-remitting multiple sclerosis was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: TERMINATED